Humiglim M2 Dapa Tab

Composition

Glimepiride 2 mg + Metformin (as hydrochloride) 500 mg + Dapagliflozin 10 mg (tablet)

Uses of Humiglim M2 Dapa Tab

Type 2 diabetes mellitus—adjunct to diet and exercise to improve glycaemic control in adults when dual/monotherapy is inadequate.

• •Lowers fasting and post-meal blood sugar
• •Improves insulin sensitivity and reduces liver glucose output
• •Promotes glucose excretion via urine
• •Helps achieve better HbA1c control
• •May support modest weight reduction with SGLT2 component

How it works

Glimepiride (sulfonylurea) increases insulin release from pancreatic beta cells. Metformin reduces hepatic glucose production and improves insulin sensitivity. Dapagliflozin (SGLT2 inhibitor) increases urinary glucose excretion by reducing glucose reabsorption in the kidneys.

Directions for use

Oral tablet; take exactly as prescribed. Usually taken once daily with food (preferably with breakfast) to reduce stomach upset and hypoglycaemia risk; swallow whole with water. Regularly monitor blood glucose; do not stop or change dose without medical advice.

Side effects

Common side effects of Humiglim M2 Dapa Tab may include:

• •Hypoglycaemia
• •dizziness
• •headache
• •